Lemaitre Vascular INC Form 4 insider transactions
NASDAQ
Director John A. Roush acquired shares of Lemaitre Vascular Inc. through the release of dividend equivalent rights associated with vesting restricted stock units and performance stock units.
NASDAQ
LeMaitre Vascular's CEO, George W. LeMaitre, reported the acquisition of shares through the vesting of stock units and the subsequent withholding of shares to cover tax obligations.
NASDAQ
Director Martha Shadan acquired shares of Lemaitre Vascular Inc. through the release of dividend equivalent rights associated with previously granted stock awards.
NASDAQ
Senior VP of Operations at Lemaitre Vascular, Trent G. Kamke, reports stock transactions related to the vesting of restricted stock units and performance stock units.
NASDAQ
Director Martha Shadan acquired 1,725 shares of Lemaitre Vascular common stock through the release of dividend equivalent rights.
NASDAQ
Lemaitre Vascular Inc. reports the release of dividend equivalent rights, resulting in the acquisition of common stock by an insider.
NASDAQ
A Lemaitre Vascular Inc. executive acquired shares through the release of dividend equivalent rights associated with a restricted stock unit award.
NASDAQ
Lemaitre Vascular Inc. has reported the release of dividend equivalent rights and the subsequent acquisition of common stock on a one-for-one basis.
NASDAQ
Lawrence J. Jasinski, an executive at Lemaitre Vascular Inc., acquired shares through the release of dividend equivalent rights.
NASDAQ
Senior VP of Operations at LeMaitre Vascular, Trent G. Kamke, reports the acquisition of shares through dividend equivalent rights and the disposal of shares to cover tax obligations.
NASDAQ
Form 4: LeMaitre Vascular CFO Reports Stock Transactions Following Vesting of Restricted Stock Units
LeMaitre Vascular's Chief Financial Officer, Joseph P. Pellegrino Jr., reported the acquisition of shares through dividend equivalent rights and the disposal of shares to cover tax obligations related to vested restricted stock units.
NASDAQ
Lemaitre Vascular Inc.'s President and Director, David B. Roberts, acquired shares through the release of dividend equivalent rights, as part of a restricted stock unit vesting.
NASDAQ
LeMaitre Vascular's CEO, George W. LeMaitre, acquired shares through the release of dividend equivalent rights and a tax withholding transaction.
NASDAQ
LeMaitre Vascular's CEO, George W. LeMaitre, received stock options and restricted stock units as part of his compensation package.
NASDAQ
Lemaitre Vascular Inc. grants stock options and restricted stock units to executive Martha Shadan.
NASDAQ
Director John A. Roush of Lemaitre Vascular Inc. reported acquiring shares and stock options, while also disposing of some shares.
NASDAQ
Director Bridget A. Ross acquired 420 shares of common stock and 2,594 stock options in Lemaitre Vascular, Inc.
NASDAQ
Lemaitre Vascular Inc. has granted stock options and restricted stock units to executive John James O'Connor.
NASDAQ
Director Lawrence J. Jasinski of Lemaitre Vascular, Inc. acquired 420 shares of common stock and 2,594 stock options on December 6, 2024.
NASDAQ
Lemaitre Vascular Inc.'s Chief Financial Officer, Joseph P. Pellegrino Jr., received stock options and restricted stock units as part of his compensation package.
NASDAQ
Lemaitre Vascular Inc. has granted stock options and restricted stock units to Senior Vice President of Operations, Trent G. Kamke.
NASDAQ
David B. Roberts, President and Director of Lemaitre Vascular, acquired 1,335 shares of common stock and 7,662 stock options on December 6, 2024.
NASDAQ
Director Martha Shadan of Lemaitre Vascular Inc. reported the acquisition of dividend equivalent rights related to previously granted stock awards.
NASDAQ
Director John A. Roush of Lemaitre Vascular Inc. reported the acquisition of dividend equivalent rights related to previously granted stock awards.
NASDAQ
Form 4: Director Bridget A. Ross Reports Acquisition of Dividend Equivalent Rights in LeMaitre Vascular Inc.
Director Bridget A. Ross acquired dividend equivalent rights related to previously granted restricted stock units and performance share units in LeMaitre Vascular Inc.
NASDAQ
Form 4: Director John O'Connor Reports Acquisition of Dividend Equivalent Rights in LeMaitre Vascular
Director John O'Connor acquired dividend equivalent rights related to previously granted stock awards in LeMaitre Vascular.
NASDAQ
Form 4: Lemaitre Vascular Director Lawrence J. Jasinski Reports Acquisition of Dividend Equivalent Rights
Director Lawrence J. Jasinski of Lemaitre Vascular Inc. reported the acquisition of dividend equivalent rights related to previously granted stock awards.
NASDAQ
Senior VP of Operations at Lemaitre Vascular, Trent G. Kamke, acquired dividend equivalent rights related to previously granted stock awards.
NASDAQ
Joseph P. Pellegrino Jr., CFO of Lemaitre Vascular, acquired dividend equivalent rights related to previously granted restricted stock units and performance share units.
NASDAQ
Form 4: Lemaitre Vascular Inc. Executive David B. Roberts Reports Acquisition of Dividend Equivalent Rights
David B. Roberts, President and Director of Lemaitre Vascular Inc., reported the acquisition of dividend equivalent rights related to previously granted stock awards.